Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Aquestive Therapeutics Inc (AQST)

175 + Investors. Track Smart Money conviction in AQST. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -4
Streak
1Q ▼
Buyers last Q
51%

Smart Money Signals — AQST

Based on 177 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their AQST positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
177 hedge funds hold AQST right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +45% more funds vs a year ago

fund count last 6Q
+55 new funds entered over the past year (+45% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 51% buying

105 buying99 selling
Last quarter: 105 funds bought or added vs 99 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~47 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 15 → 50 → 50 → 47. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 33% long-term, 41% new

■ 33% conviction (2yr+) ■ 27% medium ■ 41% new
Of the 177 current holders: 58 (33%) held >2 years, 47 held 1–2 years, and 72 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares -9%, value -39%

Value
-39%
Shares
-9%
Last quarter: funds added -9% more shares while total portfolio value only changed -39%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

29 → 15 → 50 → 50 → 47 new funds/Q
New funds entering each quarter: 15 → 50 → 50 → 47. A growing number of institutions are discovering AQST each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 42% of holders stayed 2+ years

■ 42% veterans ■ 16% 1-2yr ■ 43% new
Of 183 current holders: 76 (42%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 27% AUM from major funds

27% from top-100 AUM funds
37 of 177 holders rank in the top 100 by AUM, accounting for 27% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.7
out of 10
Moderate Exit Risk
Exit risk score 4.7/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — AQST

In 2026 Q1, 105 hedge funds were net buyers of AQST (47 opened a new position, 58 added to an existing one), while 99 reduced or exited (48 trimmed, 51 sold completely) — a 51% buyer ratio, indicating a slight buying edge. 27% of total institutional value in AQST is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -4 funds (more exits than new entries). Total institutional holders: 177.

Hedge Fund Ownership: AQST

How many hedge funds hold AQST — quarterly history vs. share price
Quarterly hedge fund ownership of AQST vs. share price

Market Analysis: AQST

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: AQST

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Aquestive Therapeutics Inc (AQST) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much AQST has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 81d ago
AQST
+13.5%
XLV
+2.1%

AQST outperformed XLV by +11.4% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 36d ago
AQST
+12.9%
XLV
+3.2%

Since the filing became public, AQST outperformed XLV by +9.7% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

17 top-rated funds 1 high-conviction
Consensus
5.5
/ 10
breadth
×
Elite
2.0
/ 10
conviction
Hedge Fund Positioning: AQST
175 + Investors

Track Smart Money conviction in AQST. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 175 181 -3.31%
13F Shares 68M 75M -9.21%
Total Value $294M $484M -39.4%
New Positions 46 50 -4
Increased Positions 58 68 -10
Closed Positions 52 22 +30
Reduced Positions 44 39 +5
Total Calls 3 6 -50.0%
Total Puts 3 8 -62.5%
PUT/CALL Ratio 1.0 1.33 Neutral

Statistics: AQST

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

175 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in AQST. Verified SEC 13F-HR filings.

QUARTER:
Top 25 AQST holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Bratton Capital Management, L.P. 100.00% 9,810,958 $40.7M
2 Propel Bio Management, LLC 1.86% 710,988 $3.0M
3 Blue Owl Capital Holdings LP 1.50% 1,347,932 $5.6M
4 Everstar Asset Management, LLC 1.22% 553,181 $2.3M
5 Sio Capital Management, LLC 1.14% 1,922,887 $8.0M
6 Samsara BioCapital, LLC 1.01% 2,500,000 $10.4M
7 Latash Investments, LLC 0.78% 243,134 $1.0M
8 Rosalind Advisors, Inc. 0.42% 250,000 $1.0M
9 Diametric Capital, LP 0.36% 335,443 $1.4M
10 DAFNA Capital Management LLC 0.35% 368,415 $1.5M
11 Rtw Investments, LP 0.31% 7,426,471 $30.8M
12 Sugar Maple Asset Management, LLC 0.15% 58,060 $241K
13 AWM Investment Company, Inc. 0.12% 270,400 $1.1M
14 Penbrook Management LLC 0.08% 25,565 $106K
15 Bracebridge Capital, LLC 0.05% 459,216 $1.9M
16 Scientech Research LLC 0.05% 13,181 $55K
17 Corsair Capital Management, L.P. 0.04% 70,000 $290K
18 Summit Wealth & Retirement Planning, INC. 0.03% 35,000 $145K
19 Adirondack Capital Advisors, LLC 0.03% 12,000 $50K
20 Cox Capital Mgt LLC 0.03% 10,500 $44K
21 Axq Capital, LP 0.03% 47,968 $199K
22 Wasatch Advisors LP 0.02% 878,316 $3.6M
23 Federated Hermes, INC. 0.02% 2,940,339 $12.2M
24 Drive Wealth Management, LLC 0.02% 20,537 $85K
25 Quantbot Technologies LP 0.02% 103,446 $429K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Aquestive Therapeutics Inc (AQST)

What does the Smart Money Trend signal show for AQST?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their AQST positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for AQST?

Slight buying edge — 51% buying: Last quarter: 105 funds bought or added vs 99 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for AQST holders?

Strong quality — 27% AUM from major funds: 37 of 177 holders rank in the top 100 by AUM, accounting for 27% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held AQST?

Mixed — 33% long-term, 41% new: Of the 177 current holders: 58 (33%) held >2 years, 47 held 1–2 years, and 72 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Aquestive Therapeutics Inc (AQST) following the 2026 Q1 hedge fund 13F filings?

As of today, AQST has moved +12.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of +9.7%. Since the quarter end (March 31, 2026), AQST has gained +13.5% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →